Literature DB >> 22348286

Tissue factor expression determines tumour cell coagulation kinetics.

J Welsh1, J D Smith, K R Yates, J Greenman, A Maraveyas, L A Madden.   

Abstract

INTRODUCTION: Cancers are associated with varying degrees of an increased risk of venous thromboembotic events (VTE) occurring. This increased risk is tumour driven and associated with tumour expression of tissue factor (TF) and tumour-derived microparticles (MP). In this study, cancer cell lines from phenotypically distinct tumours were assessed for cell surface TF expression and prothrombin time (PT) taken as a measure of procoagulant potential.
METHODS: Breast (T47D, MCF-7), colorectal (Colo320 and LoVo), head and neck (USCC 11b, 12, 81b and SIHN-011A) and pancreatic tumour cell lines (ASPC-1 and CFPAC-1) were assessed for TF expression by flow cytometry and relative mean fluorescence determined. Procoagulant potential of the cells was then determined by PT assay.
RESULTS: Cell-supported coagulation was shown to be cell number dependent, defined by a logarithmic relationship that was consistent across all cell lines. Single cell PT was determined for each cell line from the slope of a logarithmically transformed data plot. A near linear relationship was observed between TF expression and single cell clotting time where a higher expression of TF results in a proportionally faster PT (P < 0.001).
CONCLUSIONS: This study shows that across a range of tumour sites a consistent relationship is seen between procoagulant potential and both cell number and TF cell surface expression.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22348286     DOI: 10.1111/j.1751-553X.2012.01409.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  14 in total

1.  Successful Treatment of Recurrent Thrombosis Associated with Malignancy with Apixaban and Follow-up for 1 Year.

Authors:  Timothy Boey; Ashita Ashish Sule; Ashish Anil Sule
Journal:  Int J Angiol       Date:  2019-08-07

2.  Preoperative D-dimers as an independent prognostic marker in cervical carcinoma.

Authors:  Yao-Ling Luo; Pei-Dong Chi; Xin Zheng; Lin Zhang; Xue-Ping Wang; Hao Chen
Journal:  Tumour Biol       Date:  2015-06-14

3.  The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation.

Authors:  Kevin G Phillips; Angela M Lee; Garth W Tormoen; Rachel A Rigg; Anand Kolatkar; Madelyn Luttgen; Kelly Bethel; Lyudmila Bazhenova; Peter Kuhn; Paul Newton; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2014-11-19       Impact factor: 4.249

4.  Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor.

Authors:  Garth W Tormoen; Ayesha Khader; András Gruber; Owen J T McCarty
Journal:  Phys Biol       Date:  2013-04-15       Impact factor: 2.583

Review 5.  Metastasis review: from bench to bedside.

Authors:  Ali Mohammad Alizadeh; Sadaf Shiri; Sadaf Farsinejad
Journal:  Tumour Biol       Date:  2014-08-08

6.  Do circulating tumor cells play a role in coagulation and thrombosis?

Authors:  Garth W Tormoen; Kristina M Haley; Ross L Levine; Owen J T McCarty
Journal:  Front Oncol       Date:  2012-09-10       Impact factor: 6.244

7.  Modeling and simulation of procoagulant circulating tumor cells in flow.

Authors:  Angela M Lee; Garth W Tormoen; Eva Kanso; Owen J T McCarty; Paul K Newton
Journal:  Front Oncol       Date:  2012-09-14       Impact factor: 6.244

8.  Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cells.

Authors:  Yang Zhao; Daohai Zhang; Sheng Wang; Li Tao; Aiyun Wang; Wenxing Chen; Zhijie Zhu; Shizhong Zheng; Xiang Gao; Yin Lu
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

9.  Development of coagulation factor probes for the identification of procoagulant circulating tumor cells.

Authors:  Garth W Tormoen; Flor A Cianchetti; Paul E Bock; Owen J T McCarty
Journal:  Front Oncol       Date:  2012-09-06       Impact factor: 6.244

Review 10.  Tissue factor in tumor microenvironment: a systematic review.

Authors:  Xiao Han; Bo Guo; Yongsheng Li; Bo Zhu
Journal:  J Hematol Oncol       Date:  2014-08-01       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.